The critical DNA damage by benzo(a)pyrene in lung tissues of smokers and approaches to preventing its formation

Toxicology Letters

Volumn 198, Issue 1, 2010, Pages 63-68

  Alexandrov, Kroum ^a   Rojas, Margarita ^b   Satarug, Soisungwan ^c  

^a CNRS   (France)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Benzo(a)pyrene; BPDE dG adduct; Cadmium; Cigarette smoke; Food contaminant; Lung cancer

Indexed keywords

BENZO[A]PYRENE; BENZO[A]PYRENE 7,8 DIHYDRODIOL 9,10 OXIDE; CADMIUM; CIGARETTE SMOKE; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 1B1;

AIR POLLUTION; BRONCHUS MUCOSA; CANCER RISK; DNA ADDUCT; DNA DAMAGE; FOOD CONTAMINATION; HUMAN; LUNG CANCER; PRIORITY JOURNAL; REVIEW; SMOKING; SMOKING CESSATION;

EID: 77955583308     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2010.04.009     Document Type: Review

References (51)

1. Alexandrov K., Rojas M., Geneste O., Castegnaro M., Camus A.M., Petruzzelli S., Giuntini C., Bartsch H. An improved fluorometric assay for dosimetry of benzo(a)pyrene diol-epoxide-DNA adducts in smokers' lung: comparisons with total bulky adducts and aryl hydrocarbon hydroxylase activity. Cancer Res. 1992, 52:6248-6253.
2. Alexandrov K., Rojas M., Rolando C. DNA damage by benzo(a)pyrene in human cells is increased by cigarette smoke and decreased by a filter containing rosemary extract which lowers free radicals. Cancer Res. 2006, 66:11938-11945.
3. Anderson K.E., Kadlubar F.F., Kulldorff M., Harnack L., Gross M., Lang N.P., Barber C., Rothman N., Sinha R. Dietary intake of heterocyclic amines and benzo(a)pyrene: associations with pancreatic cancer. Cancer Epidemiol. Biomarkers Prev. 2005, 14:2261-2265.
4. Arif J.M., Dresler C., Clapper M.L., Gairola C.G., Srinivasan C., Lubet R.A., Gupta R.C. Lung DNA adducts detected in human smokers are unrelated to typical polyaromatic carcinogens. Chem. Res. Toxicol. 2006, 19:295-299.
5. Boysen G., Hecht S.S. Analysis of DNA and protein adducts of benzo[a]pyrene in human tissues using structure-specific methods. Mutat. Res. 2003, 543:17-30.
6. Conney A.H. Induction of drug-metabolizing enzymes: a path to the discovery of multiple cytochromes P450. Ann. Rev. Pharmacol. Toxicol. 2003, 43:1-30.
7. Cox L.A. Quantifying potential health impacts of cadmium in cigarettes on smoker risk of lung cancer: a portfolio-of-mechanisms approach. Risk Anal. 2006, 26:1581-2199.
8. Deutsch-Wenzel R., Brune H., Grimmer G. Experimental studies in rat lungs on the carcinogenicity and dose-response relationships of eight frequently occurring environmental polycyclic aromatic hydrocarbons. J. Natl. Cancer Inst. 1983, 71:539-544.
9. Ding X., Kaminski L.S. Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts. Annu. Rev. Pharmacol. Toxicol. 2003, 43:149-173.
10. Gelboin H.V. Benzo[a]pyrene metabolism, activation and carcinogenesis: role and regulation of mixed-function oxidases and related enzymes. Physiol. Rev. 1980, 60:1107-1166.
11. Ginsberg G.L., Atherholt T.B. DNA adduct formation in mouse tissues in relation to serum levels of benzo(a)pyrene-diol-epoxides after injection of benzo(a)pyrene or diol-epoxide. Cancer Res. 1990, 50:1189-1194.
12. Grasseschi R.M., Ramaswamy R.B., Levine D.J., Klaassen C.D., Wesselius L.J. Cadmium accumulation and detoxification by alveolar macrophages of cigarette smokers. Chest 2003, 124:1924-1928.
13. Hecht S.S. Approaches to chemoprevention of lung cancer based on carcinogens in tobacco smoke. Environ. Health Perspect. 1997, 105:955-963.
14. Hecht S.S. Inhibition of carcinogenesis by isothiocyanates. Drug Metab. Rev. 2000, 32:395-411.
15. Hecht S.S. Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat. Rev. Cancer 2003, 3:733-744.
16. Hecht S.S., Chen M., Yagi H., Jerina D.M., Carmel S.G. r-1,t-2,3,c-4-Terahydroxy-1,2,3,4-tetrahydrophenanthrene in human urine: a potential biomarker for assessing polycyclic aromatic hydrocarbon metabolic activation. Cancer Epidemiol. Biomarkers Prev. 2003, 12:1501-1508.
17. Hecht S.S., Kenney P.M.J., Wang M., Updhyaya P. Dose-response study of myo-inositol as an inhibitor of lung tumorigenesis induced in A/J mice by benzo(a)pyrene and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butane. Cancer Lett. 2000, 167:1-6.
18. IARC (Internal Agency for Research on Cancer), 1993. Beryllium, cadmium, mercury and exposures in the glass manufacturing industry. In: IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Humans, vol. 58, pp. 119-238.
19. Jin T., Nordberg G., Wu X., Ye T., Kong Q., Wang Z., Zhuang F., Cai S. Urinary N-acetyl-β-d-glucosaminidase isoenzymes as a biomarker of renal dysfunction caused by cadmium in a general population. Environ. Res. 1999, 81:167-173.
20. Koul A., Tanwar L., Arora N. Celecoxib administration exhibits tissue specific effect on 3H-benzo(a)pyrene-DNA adduct formation in cigarette smoke inhaling mice. Indian J. Exp. Biol. 2009, 47:83-90.
21. Kulkarni M.S., Anderson W. Persistence of benzo(a)pyrene metabolic:DNA adducts in lung and liver of mice. Cancer Res. 1984, 44:97-101.
22. Kushman M.E., Kabler S.L., Fleming M.H., Ravoori S., Gupta R.C., Doehmer J., Morrow C.S., Townsend A.J. Expression of human glutathione S-transferase P1 confers resistance to benzo[a]pyrene or benzo[a]pyrene-7,8-dihydrodiol mutagenesis, macromolecular alkylation and formation of stable N2-Gua-BPDE adducts in stably transfected V79MZ cells co-expressing hCYP1A1. Carcinogenesis 2007, 28:207-214.
23. Leng S., Stidley C.A., Bernauer A.M., Picchi M.A., Sheng X., Frasco M.A., Van Den Berg D., Gilliland F.D., Crowell R.E., Belinsky S.A. Haplotypes of DNMT1 and DNMT3B are associated with mutagen sensitivity induced by benzo[a]pyrene diol epoxide among smokers. Carcinogenesis 2008, 29:1380-1385.
24. Meplan C., Mann K., Hainaut P. Cadmium induces conformational modifications of wild-type p53and suppresses p53 response to DNA damage in cultured cells. J. Biol. Chem. 1999, 274:31663-31670.
25. Miller J.A. Research in chemical carcinogenesis with Elizabeth Miller - a trail discovery with our associates. Drug Metab. Dispos. 1994, 43:1-36.
26. Mukherjee J.J., Gupta S.K., Kumar S., Sikka H.C. Effects of cadmium(II) on (+/-)-anti-benzo[a]pyrene-7,8-diol-9,10-epoxide-induced DNA damage response in human fibroblasts and DNA repair: a possible mechanism of cadmium's cogenotoxicity. Chem. Res. Toxicol. 2004, 17:287-293.
27. Nakamura Y., Miyoshi N. Cell death induction by isothiocyanates and their underlying molecular mechanisms. Biofactors 2006, 26:123-134.
28. Nakayama T., Kaneko M., Kodama M., Nagata C. Cigarette smoke induces DNA single-strand breaks in human cells. Nature 1985, 314:462-464.
29. Nawrot T., Plusquin M., Hogervorst J., Roels H.A., Celis H., Thijs L., Vangronsveld J., Van Hecke E., Staessen J.A. Environmental exposure to cadmium and risk of cancer: a prospective population-based study. Lancet Oncol. 2006, 7:119-126.
30. Nesnow S., Ross J.A., Stoner G.D., Mass M.J. Mechanistic linkage between DNA adducts, mutations in oncogenes and tumorigenesis of carcinogenic polycyclic aromatic hydrocarbons in strain A/J mice. Toxicology 2000, 103:403-413.
31. Osada H., Takahashi T. Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer. Oncogene 2002, 21:7421-7434.
32. Osborn M.R., Crosby T.N. Benzopyrenes. Cambridge Monographs on Cancer Research 1987, Cambridge University Press, Cambridge, pp. 1-323.
33. Park I.W., Wistuba I.I., Maitra A., Milchgrub S., Virmani A.K., Minna J.D., Gazdar A.F. Multiple clonal abnormalities in the bronchial epithelium of patients with lung cancer. J. Natl. Cancer Inst. 1999, 91:1863-1868.
34. Pryor W.A. Cigarette smoke radicals and the role of free radicals in chemical carcinogenicity. Environ. Health Perspect. 1997, 105:875-882.
35. Rojas M., Alexandrov K., Cascorbi I., Brockmöller J., Likhachev A., Pozharisski K., Bouvier G., Auburtin G., Mayer L., Kopp-Schneider A., Roots I., Bartsch H. High benzo[a]pyrene diol-epoxide DNA adduct levels in lung and blood cells from individuals with combined CYP1A1 MspI/Msp-GSTM1*0/*0 genotypes. Pharmacogenetics 1998, 8:109-118.
36. Rojas M., Marie B., Vignaud J.M., Martinet N., Siat J., Grosdidier G., Cascorbi I., Alexandrov K. High DNA damage by benzo[a]pyrene 7,8-diol-9,10-epoxide in bronchial epithelial cells from patients with lung cancer: comparison with lung parenchyma. Cancer Lett. 2004, 207:157-163.
37. Schwerdtle T., Ebert F., Thuy C., Richter C., Mullenders L.H., Hartwig A. Genotoxicity of soluble and particulate cadmium compounds: impact on oxidative DNA damage and nucleotide excision repair. Chem. Res. Toxicol. 2010, 23:432-442.
38. Satarug S., Baker J.R., Reilly P.E.B., Moore M.R., Williams D.J. Cadmium levels in the lung, liver, kidney cortex and urine samples from Australians without occupational exposure to metals. Arch. Environ. Health 2002, 57:69-77.
39. Satarug S., Tassaneeyakul W., Na-Bangchang K., Cashman J.R., Moore M.R. Genetic and environmental influences on therapeutic and toxicity outcomes: studies with CYP2A6. Cur. Clin. Pharmacol. 2006, 1:291-309.
40. Sinha R., Kulldorff M., Gunter M.J., Strickland P., Rothman N. Dietary benzo[a]pyrene intake and risk of colorectal adenoma. Cancer Epidemiol. Biomarkers Prev. 2005, 14:2030-2034.
41. Sticha K.R., Kenney P.M., Boysen G., Liang H., Su X., Wang M., Upadhyaya P., Hecht S.S. Effects of benzyl isothiocyanate and phenethyl isothiocyanate on DNA adduct formation by a mixture of benzo[a]pyrene and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in A/J mouse lung. Carcinogenesis 2002, 23:1433-1439.
42. Sticha K.R.K., Staretz M.E., Wang M., Liang H., Kenney P.M.J., Hecht S.S. Effects of benzyl isothiocyanate and phenethyl isothiocyanate on benzo(a)pyrene metabolism and DNA adduct formation in the A/J mouse. Carcinogenesis 2000, 21:1711-1719.
43. Swauger J.E., Steichen T.J., Murphy P.A., Kinsler S. An analysis of the mainstream smoke chemistry of samples of the US cigarette market acquired between 1995 and 2000. Regul. Toxicol. Pharmacol. 2002, 35:142-156.
44. Takiguchi M., Achanzar W.E., Qu W., Li G., Waalkes M.P. Effects of cadmium on DNA-(Cytosine-5) methyltransferase activity and DNA methylation status during cadmium-induced cellular transformation. Exp. Cell Res. 2003, 286:355-365.
45. Trush M.A., Kensler T.W. Role of the free radicals in carcinogen activation. Oxidative Stress: Oxidants and Antioxidants 1991, 227-318. Academic Press, New York. H. Sies (Ed.).
46. Waldman J.M., Lioy P.J., Greenberg A., Butler J.P. Analysis of human exposure to benzo(a)pyrene via inhalation and food ingestion in the total environmental exposure study (THEES). J. Exp. Anal. Environ. Epidemiol. 1991, 1:193-225.
47. Wall K.L., Gao W., Koppele J.M., Kwei G.Y., Kauffman F.C., Thurman R.G. The liver plays a central role in the mechanism of chemical carcinogenesis due to polycyclic aromatic hydrocarbons. Carcinogenesis 1985, 12:783-786.
48. Wani M.A., Zhu Q., El-Mahdy M., Venkatachalam S., Wani A.A. Enhanced sensitivity to anti-benzo(a)pyrene-diol-epoxide DNA damage correlates with decreased global genomic repair attributable to abrogated p53 function in human cells. Cancer Res. 2000, 60:2273-2280.
49. Wiese F.W., Thompson P.A., Kadlubar F.F. Carcinogen substrate specificity of human COX-1 and COX-2. Carcinogenesis 2001, 21:5-10.
50. Wistuba I.I., Mao I., Gazdar A.F. Smoking molecular damage in bronchial epithelium. Oncogene 2002, 21:7298-7306.
51. Zhang Y., Talalay P. Anticarcinogenic activation of organic isothiocyanates: chemistry and mechanism. Cancer Res. 1994, 54:1976s-1981s.